Heme oxygenase-1: A metabolic nike

Antioxidants and Redox Signaling

Volumn 20, Issue 11, 2014, Pages 1709-1722

  Wegiel, Barbara ^a   Nemeth, Zsuzsanna ^a,b   Correa Costa, Matheus ^a   Bulmer, Andrew C ^c   Otterbein, Leo E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; FERRITIN; HEME OXYGENASE 1; HEMOPROTEIN; IRON; OXIDOREDUCTASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANTIOXIDANT ACTIVITY; BIOENERGY; CELL METABOLISM; CELL RESPIRATION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; METABOLIC SYNDROME X; MITOCHONDRION; MOLECULAR INTERACTION; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOSYNTHETIC PATHWAYS; CARBON MONOXIDE; CELL RESPIRATION; DIABETES MELLITUS; HEME; HEME OXYGENASE-1; HEMEPROTEINS; HUMANS; IRON; MITOCHONDRIA; NEOPLASMS;

EID: 84896380454     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5667     Document Type: Review

References (129)

1. Abraham NG, Lutton JD, and Levere RD. Heme metabolism and erythropoiesis in abnormal iron states: role of delta-aminolevulinic acid synthase and heme oxygenase. Exp Hematol 13: 838-843, 1985.
2. Abraham NG, Tsenovoy PL, McClung J, and Drummond GS. Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des 14: 412-421, 2008.
3. Ahlstrom K, Biber B, Aberg A, Waldenstrom A, Ronquist G, Abrahamsson P, Stranden P, Johansson G, and Haney MF. Metabolic responses in ischemic myocardium after inhalation of carbon monoxide. Acta Anaesthesiol Scand 53: 1036-1042, 2009.
4. Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Mi-cheletto G, and Invitti C. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects. Int J Obes (Lond) 31: 1826-1831, 2007.
5. Almeida AS, Queiroga CS, Sousa MF, Alves PM, and Vieira HL. Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2. J Biol Chem 287: 10761-10770, 2012.
6. Andersson C, Weeke P, Fosbol EL, Brendorp B, Kober L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, and Torp-Pedersen C. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism 58: 1109-1115, 2009.
7. Bao W, Song F, Li X, Rong S, Yang W, Wang D, Xu J, Fu J, Zhao Y, and Liu L. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes melli-tus: a HuGE review and meta-analysis. Am J Epidemiol 172: 631-636, 2010.
8. Bao W, Song F, Li X, Rong S, Yang W, Zhang M, Yao P, Hao L, Yang N, Hu FB, and Liu L. Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One 5: e12371, 2010.
9. Becker JC, Fukui H, Imai Y, Sekikawa A, Kimura T, Yamagishi H, Yoshitake N, Pohle T, Domschke W, and Fujimori T. Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand J Gastroenterol 42: 852-858, 2007.
10. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Bü chler MW, Friess H. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11: 3790-3798, 2005.
11. Bilban M, Bach FH, Otterbein SL, Ifedigbo E, de Costa d'Avila J, Esterbauer H, Chin BY, Usheva A, Robson SC, Wagner O, and Otterbein LE. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 24: 601-610, 2006.
12. Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, and Otterbein LE. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 86: 267-279, 2008.
13. Boon A-C, Hawkins CL, Bisht K, Bakrania B, Coombes JS, Wagner K-H, and Bulmer AC. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert's syndrome. Free Radic Biol Med 52: 2120-2127, 2012.
14. Boschetto P, Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Marian E, Querzoli P, Pedriali M, Murer B, De Rosa E, Fabbri LM, and Mapp CE. Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung Cancer 59: 192-197, 2008.
15. Breimer LH, Wannamethee G, Ebrahim S, and Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41: 1504-1508, 1995.
16. Brunt KR, Wu J, Chen Z, Poeckel D, Dercho RA, Melo LG, Funk CD, Ward CA, and Li RK. Ex vivo Akt/HO-1 gene therapy to human endothelial progenitor cells enhances myocardial infarction recovery. Cell Transplant 21: 1443-1461, 2012.
17. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, and Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199: 390-396, 2008
18. Bulmer AC, Verkade HJ, and Wagner KH. Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection. Prog Li-pid Res 52: 193-205, 2013.
19. Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, and Lin SC. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 91: 1551-1555, 2004.
20. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
21. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ, and Otterbein LE. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 104: 5109-5114, 2007.
22. Correa-Costa M, Azevedo H, Amano MT, Goncalves GM, Hyane MI, Cenedeze MA, Renesto PG, Pacheco-Silva A, Moreira-Filho CA, and Camara NO. Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One 7: e49569, 2012.
23. D'Amico G, Lam F, Hagen T, and Moncada S. Inhibition of cellular respiration by endogenously produced carbon monoxide. J Cell Sci 119: 2291-2298, 2006.
24. Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Mo-linolo A, Hewitt SM, Curino AC, Coso OA, and Facchinetti MM. Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77: 168-175, 2012.
25. Dennery PA, McDonagh AF, Spitz DR, Rodgers PA, and Stevenson DK. Hyperbilirubinemia results in reduced oxi-dative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med 19: 395-404, 1995.
26. Durante W. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci (Landmark Ed) 16: 2372-2388, 2011.
27. Ewing JF and Maines MD. In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: Differential distribution of isozyme 1 and 2. Mol Cell Neurosci 3: 559-570, 1992.
28. Ferenbach DA, Kluth DC, and Hughes J. Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp Nephrol 115: e33-e37, 2010.
29. Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, Micaroni M, Chaneton B, Adam J, Hedley A, Kalna G, Tomlinson IP, Pollard PJ, Watson DG, Deberardinis RJ, Shlomi T, Ruppin E, and Gottlieb E. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477: 225-228, 2011.
30. Fujii M, Inoguchi T, Sasaki S, Maeda Y, Zheng J, Kobayashi K, and Takayanagi R. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int 78: 905-919, 2010.
31. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, and Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibri-nolysis. Nat Med 7: 598-604, 2001.
32. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC, Hopkins PN, Cefalu WT, and McClain DA. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122: 3529-3540, 2012.
33. Gandini NA, Fermento ME, Salomón DG, Blasco J, Patel V, Gutkind JS, Molinolo AA, Facchinetti MM, Curino AC. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp Mol Pathol 93: 237-245, 2012.
34. Giraudi PJ, Bellarosa C, Coda-Zabetta CD, Peruzzo P, and Tiribelli C. Functional Induction of the Cystine-Glutamate Exchanger System X(c) Activity in SH-SY5Y Cells by Un-conjugated Bilirubin. PLoS One 6: e29078, 2011.
35. Goda N and Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol 95: 457-463, 2012.
36. Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, and Vazquez ES. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res 7: 1745-1755, 2009.
37. Guzek M, Jakubowski Z, Bandosz P, Wyrzykowski B, Smoczynski M, Jabloiska A, and Zdrojewski T. Inverse association of serum bilirubin with metabolic syndrome and insulin resistance in Polish population. Przegl Epidemiol 66: 495-501, 2012.
38. Hagymasi K, Kocsis I, Lengyel G, Sipos P, Ferer J, and Blazovics A. Further evidence of altered redox status of hyperbilirubinaemic patients: role of bilirubin in Gilbert syndrome. Acta Biol Szegediensis 47: 131-134, 2003.
39. Haider A, Olszanecki R, Gryglewski R, Schwartzman ML, Lianos E, Kappas A, Nasjletti A, and Abraham NG. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther 300: 188-194, 2002.
40. Han SS, Na KY, Chae DW, Kim YS, Kim S, and Chin HJ. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J Exp Med 221: 133-140, 2010.
41. Hanto DW, Maki T, Yoon MH, Csizmadia E, Chin BY, Gallo D, Konduru B, Kuramitsu K, Smith NR, Berssen-brugge A, Attanasio C, Thomas M, Wegiel B, and Otterbein LE. Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. Am J Transplant 10: 2421-2430, 2010.
42. Ho K, Klapper MH, and Dorfman LM. Kinetics of carbon monoxide binding to singly reduced human methemoglo-bin. J Biol Chem 253: 238-241, 1978.
43. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, and Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16: 250-255, 1996.
44. Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, and Petersen I. Serum bilirubin and risk of respiratory disease and death. JAMA 305: 691-697, 2011.
45. Hu CM, Lin HH, Chiang MT, Chang PF, and Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 56: 1240-1247, 2007.
46. Huang J, Simcox J, Mitchell TC, Jones D, Cox J, Luo B, Cooksey RC, Boros LG, and McClain DA. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice. FASEB J 27: 2845-2854, 2013.
47. Hwang HJ, Lee SW, and Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med 49: 1823-1828, 2011.
48. Ijssennagger N, Rijnierse A, de Wit NJ, Boekschoten MV, Dekker J, Schonewille A, Muller M, and van der Meer R. Dietary heme induces acute oxidative stress, but delayed cytotoxicity and compensatory hyperproliferation in mouse colon. Carcinogenesis 34: 1628-1635, 2013.
49. Jadhav A, Tiwari S, Lee P, and Ndisang JF. The heme oxygenase system selectively enhances the anti-inflammatory macrophage-M2 phenotype, reduces peri-cardial adiposity and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. J Pharmacol Exp Ther 345: 239-249, 2013.
50. Jenko-Praznikar Z, Petelin A, Jurdana M, and Ziberna L. Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome? Metabolism 62: 976-985, 2013.
51. Jozkowicz A, Was H, and Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007.
52. Kajimura M, Fukuda R, Bateman RM, Yamamoto T, and Suematsu M. Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 13: 157-192, 2010.
53. Kalousova M, Novotny L, Zima T, Braun M, and Vitek L. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. Cell Mol Biol (Noisy-le-grand) 51: 387-392, 2005.
54. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002.
55. Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, and Sasaki H. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116: 354-360, 2005.
56. Kim HR, Kim S, Kim EJ, Park JH, Yang SH, Jeong ET, Park C, Youn MJ, So HS, and Park R. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Lung Cancer 60: 47-56, 2008.
57. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, Ali N, Wang B, Haskard DO, Soares MP, and Mason JC. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 113: 1598-1607, 2009.
58. Kushida T, Li Volti G, Quan S, Goodman A, and Abraham NG. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem 87: 377-385, 2002.
59. Lancel S, Hassoun SM, Favory R, Decoster B, Motterlini R, and Neviere R. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther 329: 641-648, 2009.
60. Lancel S, Montaigne D, Marechal X, Marciniak C, Hassoun SM, Decoster B, Ballot C, Blazejewski C, Corseaux D, Lescure B, Motterlini R, and Neviere R. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One 7: e41836, 2012.
61. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, and Boczkowski J. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19: 1890-1892, 2005.
62. Levere RD, Martasek P, Escalante B, Schwartzman ML, and Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86: 213-219, 1990.
63. Li B, Takeda K, Ishikawa K, Yoshizawa M, Sato M, Shi-bahara S, and Furuyama K. Coordinated expression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism. Tohoku J Exp Med 228: 27-41, 2012.
64. Li M, Peterson S, Husney D, Inaba M, Guo K, Kappas A, Ikehara S, and Abraham NG. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 6: 567-571, 2007.
65. Li Y, Su J, DingZhang X, Zhang J, Yoshimoto M, Liu S, Bijian K, Gupta A, Squire JA, Alaoui Jamali MA, and Bismar TA. PTEN deletion and heme oxygenase-1 over-expression cooperate in prostate cancer progression and are associated with adverse clinical outcome. J Pathol 224: 90-100, 2011.
66. Lin H, Yu CH, Jen CY, Cheng CF, Chou Y, Chang CC, and Juan SH. Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARalpha dependent mechanism. Am J Pathol 177: 1697-1709, 2010.
67. Lin LC, Ho FM, Yen SJ, Wu PY, Hung LF, Huang WJ, and Liang YC. Carbon monoxide induces cyclooxygenase-2 expression through MAPKs and PKG in phagocytes. Int Immunopharmacol 10: 1520-1525, 2010.
68. Lo Iacono L, Boczkowski J, Zini R, Salouage I, Berdeaux A, Motterlini R, and Morin D. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 50: 1556-1564, 2011.
69. Lo SS, Lin SC, Wu CW, Chen JH, Yeh WI, Chung MY, and Lui WY. Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion. Ann Surg Oncol 14: 2250-2256, 2007.
70. Maines MD and Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci USA 71: 4293-4297, 1974.
71. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, and Higashi Y. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126: 598-603, 2012.
72. Mashreghi MF, Klemz R, Knosalla IS, Gerstmayer B, Jans-sen U, Buelow R, Jozkowicz A, Dulak J, Volk HD, and Kotsch K. Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3. J Immunol 180: 7919-7930, 2008.
73. McCarty MF. "Iatrogenic Gilbert syndrome"-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 69: 974-994, 2007.
74. Minetti M, Mallozzi C, Stazi AMMD, and Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352: 165-174, 1998.
75. Mishra S, Fujita T, Lama VN, Nam D, Liao H, Okada M, Minamoto K, Yoshikawa Y, Harada H, and Pinsky DJ. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci USA 103: 5191-5196, 2006.
76. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79, 2012.
77. Molzer C, Huber H, Steyrer A, Ziesel G, Ertl A, Plavotic A, Wallner M, Bulmer AC, and Wagner KH. In vitro antioxi-dant capacity and antigenotoxic properties of protopor-phyrin and structurally related tetrapyrroles. Free Radic Res 46: 1369-1377, 2012.
78. Mosen H, Salehi A, Henningsson R, and Lundquist I. Nitric oxide inhibits, and carbon monoxide activates, islet acid alpha-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion. J Endocrinol 190: 681-693, 2006.
79. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, Uchiyama T, Zuckerbraun BS, Nalesnik MA, Otter-bein LE, and Murase N. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 163: 1587-1598, 2003.
80. Neuzil J, Gebicki JM, and Stocker R. Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochem J 293 (Pt 3): 601-606, 1993.
81. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A, Rezzani R, Rodella LF, Drummond G, Kusmic C, L'Abbate A, Kappas A, and Abraham NG. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53: 508-515, 2009.
82. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5: 1107-1113, 1999.
83. Oda E and Kawai R. Bilirubin is negatively associated with hemoglobin a(1c) independently of other cardiovascular risk factors in apparently healthy Japanese men and women. Circ J 75: 190-195, 2011.
84. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graca-Souza AV, Liloia A, Soares MP, Otterbein LE, Usheva A, Yamashita K, and Bach FH. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112: 1030-1039, 2005.
85. Phelan D, Winter GM, Rogers WJ, Lam JC, and Denison MS. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357: 155-163, 1998.
86. Piantadosi CA, Carraway MS, Babiker A, and Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 103: 1232-1240, 2008.
87. Queiroga CS, Almeida AS, and Vieira HL. Carbon monoxide targeting mitochondria. Biochem Res Int 2012: 749845, 2012.
88. Rotenberg MO and Maines MD. Isolation, characterization, and expression in Escherichia coli of a cDNA encoding rat heme oxygenase-2. J Biol Chem 265: 7501-7506, 1990.
89. Ryter SW and Otterbein LE. Carbon monoxide in biology and medicine. Bioessays 26: 270-280, 2004.
90. Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, and Vazquez E. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 97: 1683-1689, 2007.
91. Sandouka A, Balogun E, Foresti R, Mann BE, Johnson TR, Tayem Y, Green CJ, Fuller B, and Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) modulate respiration in isolated mitochondria. Cell Mol Biol (Noisy-le-grand) 51: 425-432, 2005.
92. Sarady-Andrews JK, Liu F, Gallo D, Nakao A, Overhaus M, Ollinger R, Choi AM, and Otterbein LE. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289: L1131-L1137, 2005.
93. Schwartzman ML, Masferrer J, Dunn MW, McGiff JC, and Abraham NG. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. Curr Eye Res 6: 623-630, 1987.
94. Schwertner HA and Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198: 1-11, 2008.
95. Shepherd RE, Moreno FJ, Cashore WJ, and Fain JN. Effects of bilirubin on fat cell metabolism and lipolysis. Am J Physiol 237: E504-E508, 1979.
96. Shih RH and Yang CM. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. J Neuroin-flammation 7: 86, 2010.
97. Simon T, Anegon I, and Blancou P. Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer. Immunotherapy 3: 15-18, 2011.
98. Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Jozkowicz A, Kieda C, and Dulak J. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Anti-oxid Redox Signal 19: 644-660, 2013.
99. Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, Manthati VL, Koduru SR, Falck JR, Schwartzman ML, and Abraham NG. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 331: 906-916, 2009.
100. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 6: 841-849, 2004.
101. Stocker R and Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
102. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
103. Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, and Piantadosi CA. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 117: 3730-3741, 2007.
104. Takano N, Yamamoto T, Adachi T, and Suematsu M. Assessing a shift of glucose biotransformation by LC-MS/MS-based metabolome analysis in carbon monoxide-exposed cells. Adv Exp Med Biol 662: 101-107, 2010.
105. Tanos R, Patel RD, Murray IA, Smith PB, Patterson AD, and Perdew GH. Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner. Hepatology 55: 1994-2004, 2012.
106. Tapan S, Karadurmus N, Dogru T, Ercin CN, Tasci I, Bilgi C, Kurt I, and Erbil MK. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem 44: 300-303, 2011.
107. Temme EH, Zhang J, Schouten EG, and Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 12: 887-894, 2001.
108. Vallabhaneni R, Kaczorowski DJ, Yaakovian MD, Rao J, and Zuckerbraun BS. Heme oxygenase 1 protects against hepatic hypoxia and injury from hemorrhage via regulation of cellular respiration. Shock 33: 274-281, 2010.
109. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, and Snyder SH. Carbon monoxide: a putative neural messenger. Science 259: 381-384, 1993.
110. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, and Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bili-rubin levels. Atherosclerosis 160: 449-456, 2002.
111. Wallner M, Blassnigg SM, Marisch K, Pappenheim MT, Mullner E, Molzer C, Nersesyan A, Marculescu R, Doberer D, Knasmuller S, Bulmer AC, and Wagner KH. Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay. Mutagenesis 27: 731-735, 2012.
112. Wallner M, Bulmer AC, Moelzer C, Muellner E, Marculescu R, Doberer D, Wagner O, and Wagner K-H. Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. Eur J Clin Invest 43: 912-919, 2013.
113. Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, Bulmer AC, and Wagner KH. Protection from age related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci 125: 257-264, 2013.
114. Was H, Dulak J, and Jozkowicz A. Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 11: 1551-1570, 2010.
115. Wegiel B, Gallo D, Csizmadia E, Harris C, Belcher J, Vercellotti GM, Penacho N, Seth P, Sukhatme V, Ahmed A, Pandolfi PP, Helczynski L, Biartell A, Persson JL, and Otterbein LE. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res. 73: 7009-7021, 2013.
116. Weinberger B, Archer FE, Kathiravan S, Hirsch DS, Klein-feld AM, Vetrano AM, and Hegyi T. Effects of bilirubin on neutrophil responses in newborn infants. Neonatology 103: 105-111, 2013.
117. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Ric-cardi D, Peers C, and Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306: 2093-2097, 2004.
118. Wojakowski W, Tendera M, Cybulski W, Zuba-Surma EK, Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych L, Paslawska U, Paslawski R, Milewski K, Buszman PP, Nabialek E, Kuczmik W, Janiszewski A, Dziegiel P, Busz-man PE, Jozkowicz A, and Dulak J. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury. Thromb Haemost 108: 464-475, 2012.
119. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
120. Yesilova Z, Serdar M, Ercin CN, Gunay A, Kilciler G, Hasimi A, Uygun A, Kurt I, Erbil MK, and Dagalp K. Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome. J Gastro-enterol Hepatol 23: 1556-1560, 2008.
121. Yin Y, Liu Q, Wang B, Chen G, Xu L, Zhou H. Expression and function of heme oxygenase-1 in human gastric cancer. Exp Biol Med (Maywood) 237: 362-371, 2012.
122. Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Oketani N, Saihara K, Okui H, Shinsato T, Ichiki H, Kubozono T, Kuwahata S, Fujita S, Kanda D, Nakazaki M, Miyata M, and Tei C. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb 18: 403-412, 2011.
123. Zelenka J, Lenicek M, Muchova L, Jirsa M, Kudla M, Balaz P, Zadinova M, Ostrow JD, Wong RJ, and Vitek L. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J Chromatogr B Analyt Technol Biomed Life Sci 867: 37-42, 2008.
124. Zenke-Kawasaki Y, Dohi Y, Katoh Y, Ikura T, Ikura M, Asahara T, Tokunaga F, Iwai K, and Igarashi K. Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol 27: 6962-6971, 2007.
125. Zhang W, Qiao T, and Zha L. Inhibition of heme oxyge-nase-1 enhances the radiosensitivity in human nonsmall cell lung cancer a549 cells. Cancer Biother Radiopharm 26: 639-645, 2011.
126. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, and Lee PJ. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 278: 22061-22070, 2003.
127. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PK, Liu F, Choi AM, Bach FH, and Otterbein LE. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 198: 1707-1716, 2003.
128. Zuckerbraun BS, Chin BY, Bilban M, d'Avila JC, Rao J, Billiar TR, and Otterbein LE. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mi-tochondrial reactive oxygen species. Faseb J 21: 1099-1106, 2007.
129. Zuckerbraun BS, McCloskey CA, Gallo D, Liu F, Ifedigbo E, Otterbein LE, and Billiar TR. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 23: 527-532, 2005.